2022 spells change for EU pharmaceutical legislation
European Pharmaceutical Review
JUNE 24, 2022
COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS Pharmaceutical Strategy for Europe. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2004. This obviously presents a huge magnitude of risk for drug developers,” he noted.
Let's personalize your content